Ancora Advisors, LLC Globe Star Therapeutics Corp Transaction History

Ancora Advisors, LLC

$3.98 Billion
Q1 2024

A detailed history of Ancora Advisors, LLC transactions in Globe Star Therapeutics Corp stock. As of the latest transaction made, Ancora Advisors, LLC holds 88,000 shares of GSTC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,000

Previous 88,000 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.01 - $0.02 $880 - $1,760	88,000 New	88,000 $1,000
Q1 2022 May 13, 2022	SELL	$0.01 - $0.02 $880 - $1,760	-88,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.01 - $0.03 $360 - $1,080	36,000 Added 69.23%	88,000 $1,000
Q3 2021 Nov 15, 2021	BUY	$0.03 - $0.07 $1,560 - $3,640	52,000 New	52,000 $2,000

Others Institutions Holding GSTC

# of Institutions

Shares Held

88K

Call Options Held

Put Options Held

View Full List

About GlobeStar Therapeutics Corp

Ticker GSTC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 693,996,992
Description
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was...

More about GSTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Globe Star Therapeutics Corp Transaction History